Abstract
Both, gallbladder cancer and extrahepatic cholangiocarcinoma are rare cancers with poor prognoses. Five-year survival historically ranges from 5% to 20%. In recent years, improved survival rates have resulted from more radical operations, namely, major liver resections and extended lymph node dissections. Despite the trend favoring radical conventional operations, minimally invasive therapy retains a role in diagnosis and palliation of both, gallbladder cancer and cholangiocarcinoma. A therapeutic approach using minimal invasive surgery remains still controversial. This chapter eludes some controversial points in gallbladder carcinoma and cholangiocarcinoma knowing that both cancers carry a dismal prognosis despite surgical and nonsurgical options available.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Piehler, J.M., Crichlow, R.W.: Primary carcinoma of the gallbladder. Arch. Surg. 112(1k0), 26–30 (1977)
Wilkinson, D.S.: Carcinoma of the gall-bladder: an experience and review of the literature. Aust. N. Z. J. Surg. 65(10), 724–727 (1995)
Hadjis, N.S., Blenkharn, J.I., Alexander, N., et al.: Outcome of radical surgery in hilar cholangiocarcinoma. Surgery 107(6), 597–604 (1990)
Okuda, K., Kubo, Y., Okazaki, N., et al.: Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 39(1), 232–246 (1977)
Burke, E.C., Jarnagin, W.R., Hochwald, S.N., et al.: Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann. Surg. 228(3), 385–394 (1998)
Cubertafond, P., Gainant, A., Cucchiaro, G.: Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann. Surg. 219(3), 275–280 (1994)
Lillemoe, K.D., Cameron, J.L.: Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J. Hepatobiliary Pancreat. Surg. 7(2), 115–121 (2000)
Madariaga, J.R., Iwatsuki, S., Todo, S., et al.: Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann. Surg. 227(1), 70–79 (1998)
Sicklick, J.K., Choti, M.A.: Controversies in the surgical management of cholangiocarcinoma and gallbladder cancer. Semin. Oncol. 32(6 Suppl 9), S112–S117 (2005)
Medina, E.: Digestive diseases in Chile: epidemiologic outlook. Rev. Med. Chil. 116(3), 282–288 (1988)
Randi, G., Franceschi, S., La Vecchia, C.: Gallbladder cancer worldwide: geographical distribution and risk factors. Int. J. Cancer 118(7), 1591–1602 (2006)
Levi, F., Lucchini, F., Negri, E., La Vecchia, C.: The recent decline in gallbladder cancer mortality in Europe. Eur. J. Cancer Prev. 12(4), 265–267 (2003)
Hsing, A.W., Bai, Y., Andreotti, G., et al.: Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int. J. Cancer 121(4), 832–838 (2007)
Kapoor, V.K.: Cholecystectomy in patients with asymptomatic gallstones to prevent gall bladder cancer – the case against. Indian J. Gastroenterol. 25(3), 152–154 (2006)
Foster, J.M., Hoshi, H., Gibbs, J.F., et al.: Gallbladder cancer: defining the indications for primary radical resection and radical re-resection. Ann. Surg. Oncol. 14(2), 833–840 (2007)
Balachandran, P., Agarwal, S., Krishnani, N., et al.: Predictors of long-term survival in patients with gallbladder cancer. J. Gastrointest. Surg. 10(6), 848–854 (2006)
Rooholamini, S.A., Tehrani, N.S., Razavi, M.K., et al.: Imaging of gallbladder carcinoma. Radiographics 14(2), 291–306 (1994)
Archer, A., Horton, K.: Radiologic evaluation and treatment of gallbladder and biliary tree carcinoma. Cancer Treat. Res. 69, 157–183 (1994)
Polverosi, R., Zambelli, C., Sbeghen, R., et al.: Ultrasonography and computerized tomography in the diagnosis of gallbladder carcinoma. Radiol. Med. (Torino) 87(5), 643–647 (1994)
Akatsu, T., Aiura, K., Shimazu, M., et al.: Can endoscopic ultrasonography differentiate nonneoplastic from neoplastic gallbladder polyps? Dig. Dis. Sci. 51(2), 416–421 (2006)
Fong, Y., Wagman, L., Gonen, M., et al.: Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann. Surg. 243(6), 767–771 (2006). discussion 771-4
Shirai, Y., Wakai, T., Hatakeyama, K.: Radical lymph node dissection for gallbladder cancer: indications and limitations. Surg. Oncol. Clin. N. Am. 16(1), 221–232 (2007)
Rodriguez Otero, J.C., Proske, A., Vallilengua, C., et al.: Gallbladder cancer: surgical results after cholecystectomy in 25 patients with lamina propria invasion and 26 patients with muscular layer invasion. J. Hepatobiliary Pancreat. Surg. 13(6), 562–566 (2006)
Misra, S., Chaturvedi, A., Misra, N.C.: Gallbladder cancer. Curr. Treat Options Gastroenterol. 9(2), 95–106 (2006)
Aramaki, M., Matsumoto, T., Shibata, K., et al.: Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma. Hepatogastroenterology 51(60), 1609–1611 (2004)
Principe, A., Del Gaudio, M., Ercolani, G., et al.: Radical surgery for gallbladder carcinoma: possibilities of survival. Hepatogastroenterology 53(71), 660–664 (2006)
Misra, M.C., Guleria, S.: Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. J. Surg. Oncol. 93(8), 690–698 (2006)
Shimizu, T., Arima, Y., Yokomuro, S., et al.: Incidental gallbladder cancer diagnosed during and after laparoscopic cholecystectomy. J. Nippon Med. Sch. 73(3), 136–140 (2006)
Sun, C.D., Zhang, B.Y., Wu, L.Q., Lee, W.J.: Laparoscopic cholecystectomy for treatment of unexpected early-stage gallbladder cancer. J. Surg. Oncol. 91(4), 253–257 (2005)
Akyurek, N., Irkorucu, O., Salman, B., et al.: Unexpected gallbladder cancer during laparoscopic cholecystectomy. J. Hepatobiliary Pancreat. Surg. 11(5), 357–361 (2004)
Yeh, C.N., Jan, Y.Y., Chen, M.F.: Management of unsuspected gallbladder carcinoma discovered during or following laparoscopic cholecystectomy. Am. Surg. 70(3), 256–258 (2004)
Taner, C.B., Nagorney, D.M., Donohue, J.H.: Surgical treatment of gallbladder cancer. J. Gastrointest. Surg. 8(1), 83–89 (2004). discussion 89
Antonakis, P., Alexakis, N., Mylonaki, D., et al.: Incidental finding of gallbladder carcinoma detected during or after laparoscopic cholecystectomy. Eur. J. Surg. Oncol. 29(4), 358–360 (2003)
Shih, S.P., Schulick, R.D., Cameron, J.L., et al.: Gallbladder cancer: the role of laparoscopy and radical resection. Ann. Surg. 245(6), 893–901 (2007)
Manukyan, M.N., Demirkalem, P., Gulluoglu, B.M., et al.: Retained abdominal gallstones during laparoscopic cholecystectomy. Am. J. Surg. 189(4), 450–452 (2005)
Tumer, A.R., Yuksek, Y.N., Yasti, A.C., et al.: Dropped gallstones during laparoscopic cholecystectomy: the consequences. World J. Surg. 29(4), 437–440 (2005)
Steinert, R., Nestler, G., Sagynaliev, E., et al.: Laparoscopic cholecystectomy and gallbladder cancer. J. Surg. Oncol. 93(8), 682–689 (2006)
Ouchi, K., Mikuni, J., Kakugawa, Y.: Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J. Hepatobiliary Pancreat. Surg. 9(2), 256–260 (2002)
Giuliante, F., Ardito, F., Vellone, M., et al.: Port-sites excision for gallbladder cancer incidentally found after laparoscopic cholecystectomy. Am. J. Surg. 191(1), 114–116 (2006)
Lundberg, O., Kristoffersson, A.: Wound recurrence from gallbladder cancer after open cholecystectomy. Surgery 127(3), 296–300 (2000)
Wakai, T., Shirai, Y., Hatakeyama, K.: Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy. World J. Surg. 26(7), 867–871 (2002)
Goere, D., Wagholikar, G.D., Pessaux, P., et al.: Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg. Endosc. 20(5), 721–725 (2006)
Agrawal, S., Sonawane, R.N., Behari, A., et al.: Laparoscopic staging in gallbladder cancer. Dig. Surg. 22(6), 440–445 (2005)
Feisthammel, J., Schoppmeyer, K., Mossner, J., et al.: Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial. Am. J. Clin. Oncol. 30(3), 319–324 (2007)
Sato, K., Kitajima, Y., Kohya, N., et al.: CPT-11 (SN-38) chemotherapy may be selectively applicable to biliary tract cancer with low hMLH1 expression. Anticancer Res. 27(2), 865–872 (2007)
Gallardo, J.O., Rubio, B., Fodor, M., et al.: A phase II study of gemcitabine in gallbladder carcinoma. Ann. Oncol. 12(10), 1403–1406 (2001)
de Aretxabala, X., Roa, I., Berrios, M., et al.: Chemoradiotherapy in gallbladder cancer. J. Surg. Oncol. 93(8), 699–704 (2006)
Hong, Y.S., Lee, J., Lee, S.C., et al.: Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer. Cancer Chemother. Pharmacol. 60(3), 321–328 (2007)
Fuller, C.D., Thomas Jr., C.R., Wong, A., et al.: Image-guided intensity-modulated radiation therapy for gallbladder carcinoma. Radiother. Oncol. 81(1), 65–72 (2006)
Jepsen, P., Vilstrup, H., Tarone, R.E., et al.: Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J. Natl. Cancer Inst. 99(11), 895–897 (2007)
Fevery, J., Verslype, C., Lai, G., et al.: Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig. Dis. Sci. 52(11), 3123–3135 (2007)
Welzel, T.M., McGlynn, K.A., Hsing, A.W., et al.: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J. Natl Cancer Inst. 98(12), 873–875 (2006)
Nakeeb, A., Pitt, H.A., Sohn, T.A., et al.: Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann. Surg. 224(4), 463–473 (1996). discussion 473-5
Bismuth, H., Nakache, R., Diamond, T.: Management strategies in resection for hilar cholangiocarcinoma. Ann. Surg. 215(1), 31–38 (1992)
Kurathong, S., Lerdverasirikul, P., Wongpaitoon, V., et al.: Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case-controlled study. Gastroenterology 89(1), 151–156 (1985)
Gatselis, N.K., Tepetes, K., Loukopoulos, A., et al.: Hepatitis B virus and intrahepatic cholangiocarcinoma. Cancer Invest. 25(1), 55–58 (2007)
Wiwanitkit, V.: Seroprevalence of hepatitis virus B seropositive in the patients with cholangiocarcinoma: a summary. Asian Pac. J. Cancer Prev. 6(1), 27–28 (2005)
Seyama, Y., Makuuchi, M.: Current surgical treatment for bile duct cancer. World J. Gastroenterol. 13(10), 1505–1515 (2007)
Uchiyama, K., Nakai, T., Tani, M., et al.: Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma. Arch. Surg. 138(9), 1012–1016 (2003)
Neuhaus, P., Jonas, S., Settmacher, U., et al.: Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch. Surg. 388(3), 194–200 (2003)
Miyazaki, M., Kato, A., Ito, H., et al.: Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141(5), 581–588 (2007)
DeOliveira, M.L., Cunningham, S.C., Cameron, J.L., et al.: Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann. Surg. 245(5), 755–762 (2007)
Hasegawa, S., Ikai, I., Fujii, H., et al.: Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J. Surg. 31(6), 1258–1265 (2007)
Chung, C., Bautista, N., O’Connell, T.X.: Prognosis and treatment of bile duct carcinoma. Am. Surg. 64(10), 921–925 (1998)
Strasberg, S.M.: Resection of hilar cholangiocarcinoma. HPB Surg. 10(6), 415–418 (1998)
Patel, T., Singh, P.: Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr. Opin. Gastroenterol. 23(3), 317–323 (2007)
Liu, C.L., Fan, S.T., Lo, C.M., et al.: Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br. J. Surg. 93(12), 1488–1494 (2006)
Nagino, M., Kamiya, J., Arai, T., et al.: “Anatomic” right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann. Surg. 243(1), 28–32 (2006)
Hawkins, W.G., DeMatteo, R.P., Cohen, M.S., et al.: Caudate hepatectomy for cancer: a single institution experience with 150 patients. J. Am. Coll. Surg. 200(3), 345–352 (2005)
Nagino, M., Kamiya, J., Arai, T., et al.: One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery 137(2), 148–155 (2005)
Murakami, Y., Uemura, K., Hayashidani, Y., et al.: Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J. Surg. Oncol. 95(3), 207–212 (2007)
Grobmyer, S.R., Wang, L., Gonen, M., et al.: Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann. Surg. 244(2), 260–264 (2006)
Connor, S., Barron, E., Wigmore, S.J., et al.: The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J. Gastrointest. Surg. 9(4), 476–480 (2005)
White, R.R., Pappas, T.N.: Laparoscopic staging for hepatobiliary carcinoma. J. Gastrointest. Surg. 8(8), 920–922 (2004)
Corvera, C.U., Weber, S.M., Jarnagin, W.R.: Role of laparoscopy in the evaluation of biliary tract cancer. Surg. Oncol. Clin. N. Am. 11(4), 877–891 (2002)
DeWitt, J., Misra, V.L., Leblanc, J.K., et al.: EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest. Endosc. 64(3), 325–333 (2006)
Boberg, K.M., Jebsen, P., Clausen, O.P., et al.: Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J. Hepatol. 45(4), 568–574 (2006)
Chahal, P., Baron, T.H.: Endoscopic palliation of cholangiocarcinoma. Curr. Opin. Gastroenterol. 22(5), 551–560 (2006)
Fritscher-Ravens, A., Broering, D.C., Sriram, P.V., et al.: EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest. Endosc. 52(4), 534–540 (2000)
Savader, S.J., Prescott, C.A., Lund, G.B., Osterman, F.A.: Intraductal biliary biopsy: comparison of three techniques. J. Vasc. Interv. Radiol. 7(5), 743–750 (1996)
Rumalla, A., Baron, T.H.: Evaluation and endoscopic palliation of cholangiocarcinoma. Management of cholangiocarcinoma. Dig. Dis. 17(4), 194–200 (1999)
Chang, W.H., Kortan, P., Haber, G.B.: Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest. Endosc. 47(5), 354–362 (1998)
Farley, D.R., Weaver, A.L., Nagorney, D.M.: “Natural history” of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin. Proc. 70(5), 425–429 (1995)
Soderlund, C., Linder, S.: Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest. Endosc. 63(7), 986–995 (2006)
De Palma, G.D., Pezzullo, A., Rega, M., et al.: Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest. Endosc. 58(1), 50–53 (2003)
Cheng, J.L., Bruno, M.J., Bergman, J.J., et al.: Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest. Endosc. 56(1), 33–39 (2002)
Yoon, W.J., Lee, J.K., Lee, K.H., et al.: A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest. Endosc. 63(7), 996–1000 (2006)
Prasad, G.A., Wang, K.K., Baron, T.H., et al.: Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 5(6), 743–748 (2007)
Ortner, M.A., Dorta, G.: Technology insight: Photodynamic therapy for cholangiocarcinoma. Nat. Clin. Pract. Gastroenterol. Hepatol. 3(8), 459–467 (2006)
Zoepf, T., Jakobs, R., Arnold, J.C., et al.: Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am. J. Gastroenterol. 100(11), 2426–2430 (2005)
Wiedmann, M.W., Caca, K.: General principles of photodynamic therapy (PDT) and gastrointestinal applications. Curr. Pharm. Biotechnol. 5(4), 397–408 (2004)
Wiedmann, M., Berr, F., Schiefke, I., et al.: Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest. Endosc. 60(1), 68–75 (2004)
Witzigmann, H., Berr, F., Ringel, U., et al.: Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann. Surg. 244(2), 230–239 (2006)
Khan, S.A., Sharif, A.W., Taylor-Robinson, S.D.: Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma. Cancer Treat. Rev. 30(3), 315–318 (2004)
Mazhar, D., Stebbing, J., Bower, M.: Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? Future Oncol. 2(4), 509–514 (2006)
Charoentum, C., Thongprasert, S., Chewaskulyong, B., Munprakan, S.: Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J. Gastroenterol. 13(20), 2852–2854 (2007)
Lee, J., Kim, T.Y., Lee, M.A., et al.: Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemother. Pharmacol. 61(1), 47–52 (2008)
Heimbach, J.K., Gores, G.J., Nagorney, D.M., Rosen, C.B.: Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery 140(3), 331–334 (2006)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Pearl, J.P., Ponsky, J.L. (2011). General Considerations. In: Matteotti, R., Ashley, S. (eds) Minimally Invasive Surgical Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-45021-4_20
Download citation
DOI: https://doi.org/10.1007/978-3-540-45021-4_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-45018-4
Online ISBN: 978-3-540-45021-4
eBook Packages: MedicineMedicine (R0)